Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.52+0.43 (+1.48%)
Close on Nov 17, 2026Market cap $1.11BP/E –Yield –
Harrow pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Harrow's pe ratio was 38.8× on Oct 29, 2021, against 5.1× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Oct 29, 2021 | 38.8× | −410.2 |
| 2020 | Apr 30, 2020 | 449.0× | +436.5 |
| 2019 | Dec 31, 2019 | 12.5× | – |
See a number that looks wrong?